Mary Beth Terry

Mary Beth Terry's AcademicInfluence.com Rankings

Mary Beth Terry

Mathematics

#7300

World Rank

#9949

Historical Rank

Statistics

#818

World Rank

#908

Historical Rank

Measure Theory

#2037

World Rank

#2470

Historical Rank

mathematics Degrees

Download Badge

Mathematics

Mary Beth Terry's Degrees

PhD Biostatistics University of California, Berkeley
Masters Statistics Stanford University

Why Is Mary Beth Terry Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Mary Beth Terry's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers (2017) (1644)
Association analysis identifies 65 new breast cancer risk loci (2017) (922)
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes (2018) (559)
Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) (2011) (447)
Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk (2013) (405)
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. (2015) (390)
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population (2010) (357)
DNA methylation in white blood cells (2011) (316)
Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk (2004) (277)
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer (2017) (244)
Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts. (2002) (233)
Frequent Promoter Methylation of CDH1, DAPK, RARB, and HIC1 Genes in Carcinoma of Cervix Uteri: Its Relationship to Clinical Outcome (2003) (230)
Environmental toxins and breast cancer on Long Island. II. Organochlorine compound levels in blood. (2002) (219)
The Long Island Breast Cancer Study Project: Description of a Multi-Institutional Collaboration to Identify Environmental Risk Factors for Breast Cancer (2002) (211)
Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers (2017) (211)
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations (2018) (206)
Rare variants in the ATM gene and risk of breast cancer (2011) (200)
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. (2010) (196)
Postoperative immune function varies inversely with the degree of surgical trauma in a murine model (1997) (179)
Identification of six new susceptibility loci for invasive epithelial ovarian cancer (2014) (176)
One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer. (2005) (175)
Genomic DNA Methylation among Women in a Multiethnic New York City Birth Cohort (2008) (171)
Risk factors for advanced colorectal adenomas: a pooled analysis. (2002) (170)
Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. (2013) (163)
Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer (2010) (154)
Fruits, vegetables, and micronutrients in relation to breast cancer modified by menopause and hormone receptor status. (2004) (150)
Associations between breast cancer risk and the catalase genotype, fruit and vegetable consumption, and supplement use. (2005) (150)
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer (2018) (149)
Short telomere length and breast cancer risk: a study in sister sets. (2007) (146)
Telomere length, oxidative damage, antioxidants and breast cancer risk (2009) (145)
Aberrant promoter hypermethylation and genomic hypomethylation in tumor, adjacent normal tissues and blood from breast cancer patients. (2010) (143)
Global methylation profiles in DNA from different blood cell types (2011) (140)
Better preservation of immune function after laparoscopic-assistedvs. open bowel resection in a murine model (1996) (138)
Body fat distribution and obesity in pre- and postmenopausal breast cancer. (1999) (137)
Lifetime alcohol intake and breast cancer risk. (2006) (136)
Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma (2004) (133)
Association between Plasma 25-Hydroxyvitamin D and Breast Cancer Risk (2009) (131)
Allelic loss of chromosome 10q23 is associated with tumor progression in breast carcinomas (1998) (126)
Polymorphism in the DNA repair gene XPD, polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, and breast cancer risk. (2004) (126)
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. (2009) (124)
3-Phosphoinositide-dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinoma. (2009) (124)
Medical Advances and Racial/Ethnic Disparities in Cancer Survival (2009) (123)
Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170 (2016) (122)
Birth weight, postnatal growth, and age at menarche. (2009) (114)
Polymorphisms in XRCC1 Modify the Association between Polycyclic Aromatic Hydrocarbon-DNA Adducts, Cigarette Smoking, Dietary Antioxidants, and Breast Cancer Risk (2005) (113)
DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers (2014) (112)
Polycyclic Aromatic Hydrocarbon–DNA Adducts and Breast Cancer: A Pooled Analysis (2004) (111)
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses (2019) (110)
The impact of socioeconomic status across early life on age at menarche among a racially diverse population of girls. (2010) (106)
Prenatal Smoke Exposure and Genomic DNA Methylation in a Multiethnic Birth Cohort (2011) (105)
Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance (2012) (104)
Relationship between Urinary 15-F2t-Isoprostane and 8-Oxodeoxyguanosine Levels and Breast Cancer Risk (2006) (103)
Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia (2014) (103)
MSH6 and PMS2 germ-line pathogenic variants implicated in Lynch syndrome are associated with breast cancer (2018) (102)
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (2011) (101)
Cigarette smoking and the colorectal adenoma-carcinoma sequence: a hypothesis to explain the paradox. (1998) (100)
Body size changes in relation to postmenopausal breast cancer among women on Long Island, New York. (2005) (100)
Genetic–epigenetic interactions in cis: a major focus in the post-GWAS era (2017) (100)
Environmental exposures during windows of susceptibility for breast cancer: a framework for prevention research (2019) (100)
DNA repair capacity of lymphoblastoid cell lines from sisters discordant for breast cancer. (2005) (96)
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer (2016) (95)
10-year performance of four models of breast cancer risk: a validation study. (2019) (95)
Polymorphisms in Nucleotide Excision Repair Genes, Polycyclic Aromatic Hydrocarbon-DNA Adducts, and Breast Cancer Risk (2007) (94)
Myeloperoxidase Genotype, Fruit and Vegetable Consumption, and Breast Cancer Risk (2004) (92)
Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers (2012) (92)
Polymorphisms in Nucleotide Excision Repair Genes and DNA Repair Capacity Phenotype in Sisters Discordant for Breast Cancer (2006) (90)
Reproductive factors and breast cancer risk among older women (2006) (88)
The epidemiology of gastric cancer. (2002) (87)
Reliability in the classification of advanced colorectal adenomas. (2002) (84)
Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2 (2016) (84)
Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers. (2011) (82)
Early life socioeconomic factors and genomic DNA methylation in mid-life (2013) (81)
Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family Registry (2015) (81)
Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis. (2018) (80)
Pathology of Breast andOvarian Cancers among BRCA 1 and BRCA 2 Mutation Carriers : Results from the Consortium of Investigators of Modi fi ers of BRCA 1 / 2 ( CIMBA ) (2011) (78)
Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women with Hormone Receptor–Negative Breast Cancer (2012) (76)
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. (2016) (76)
Genetic analysis identifies putative tumor suppressor sites at 2q35–q36.1 and 2q36.3–q37.1 involved in cervical cancer progression (2003) (75)
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes (2019) (74)
Exposure to polychlorinated biphenyl (PCB) congeners measured shortly after giving birth and subsequent risk of maternal breast cancer before age 50 (2012) (73)
Serum Antioxidant Nutrients, Vitamin A, and Mortality in U.S. Adults (2013) (72)
Associations between Polycyclic Aromatic Hydrocarbon–Related Exposures and p53 Mutations in Breast Tumors (2009) (72)
Are Global Breast Cancer Incidence and Mortality Patterns Related to Country-Specific Economic Development and Prevention Strategies? (2018) (69)
IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project. (2006) (69)
Repetitive element DNA methylation levels in white blood cell DNA from sisters discordant for breast cancer from the New York site of the Breast Cancer Family Registry. (2012) (67)
Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men (1999) (67)
Racial/Ethnic Differences in Hormonally-Active Hair Product Use: A Plausible Risk Factor for Health Disparities (2012) (67)
Adult global DNA methylation in relation to pre-natal nutrition. (2012) (67)
Shared heritability and functional enrichment across six solid cancers (2018) (67)
ADH3 genotype, alcohol intake and breast cancer risk. (2006) (67)
Maternal, birth, and early-life influences on adult body size in women. (2007) (66)
HIN-1, an Inhibitor of Cell Growth, Invasion, and AKT Activation (2005) (66)
The Jerusalem Perinatal Study cohort, 1964-2005: methods and a review of the main results. (2007) (65)
Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk (2015) (65)
Alcohol Intake and Breast Cancer Risk: Weighing the Overall Evidence (2013) (64)
Treatment for breast cancer and blood levels of chlorinated hydrocarbons. (1996) (61)
Plasma protein carbonyl levels and breast cancer risk (2007) (60)
BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research (2009) (60)
MGMT genotype modulates the associations between cigarette smoking, dietary antioxidants and breast cancer risk. (2005) (60)
DDT and Breast Cancer: Prospective Study of Induction Time and Susceptibility Windows (2019) (60)
Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers (2012) (60)
The association of alcohol consumption with mammographic density in a multiethnic urban population (2015) (59)
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus (2016) (58)
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers (2014) (58)
Dietary isoflavone intake and all‐cause mortality in breast cancer survivors: The Breast Cancer Family Registry (2017) (57)
Genetic polymorphisms in the cyclooxygenase-2 gene, use of nonsteroidal anti-inflammatory drugs, and breast cancer risk (2006) (56)
Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers. (2011) (55)
Global breast cancer incidence and mortality trends by region, age-groups, and fertility patterns (2021) (53)
Genetic Polymorphisms in Folate Metabolism and the Risk of Stomach Cancer (2007) (53)
Reproductive risk factors and oestrogen/progesterone receptor-negative breast cancer in the Breast Cancer Family Registry (2014) (53)
Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer (2019) (53)
Incidence Trends of Breast Cancer Molecular Subtypes by Age and Race/Ethnicity in the US From 2010 to 2016 (2020) (53)
OGG1 Polymorphisms and Breast Cancer Risk (2006) (53)
Genetic polymorphisms in the apoptosis-associated genes FAS and FASL and breast cancer risk. (2007) (53)
Cigarette smoking and other risk factors in relation to p53 expression in breast cancer among young women. (1999) (52)
Multiple Genetic Variants in Telomere Pathway Genes and Breast Cancer Risk (2010) (52)
Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk. (2006) (50)
An international case-control study of adult diet and brain tumor risk: a histology-specific analysis by food group. (2009) (50)
Prenatal Exposure to the Pesticide DDT and Hypertension Diagnosed in Women before Age 50: A Longitudinal Birth Cohort Study (2013) (50)
Effects of glutathione S-transferase A1 (GSTA1) genotype and potential modifiers on breast cancer risk. (2006) (49)
Prenatal and childhood environmental tobacco smoke exposure and age at menarche. (2010) (49)
Cohort Profile: The Breast Cancer Prospective Family Study Cohort (ProF-SC) (2015) (48)
Rare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancers. (2014) (48)
Life course socioeconomic conditions, passive tobacco exposures and cigarette smoking in a multiethnic birth cohort of U.S. women (2009) (47)
No Increased Risk of Breast Cancer Associated with Alcohol Consumption among Carriers of BRCA1 and BRCA2 Mutations Ages <50 Years (2006) (47)
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers (2012) (47)
Commentary: The impact of fetal and infant exposures along the life course. (2001) (46)
No Association Between Glutathione Peroxidase Pro198Leu Polymorphism and Breast Cancer Risk (2005) (46)
Mutations in p53, p53 protein overexpression and breast cancer survival (2008) (46)
Dependence of cancer risk from environmental exposures on underlying genetic susceptibility: an illustration with polycyclic aromatic hydrocarbons and breast cancer (2017) (45)
Interactions among GSTM1, GSTT1 and GSTP1 polymorphisms, cruciferous vegetable intake and breast cancer risk. (2007) (45)
Leisure and occupational physical activity and risk of colorectal adenomatous polyps (1996) (45)
MnSOD Val-9Ala Genotype, Pro- and Anti-oxidant Environmental Modifiers, and Breast Cancer Among Women on Long Island, New York (2005) (45)
Cigarette smoking, body mass index, gastro-esophageal reflux disease, and non-steroidal anti-inflammatory drug use and risk of subtypes of esophageal and gastric cancers by P53 overexpression (2009) (45)
Sources of polycyclic aromatic hydrocarbons are associated with gene-specific promoter methylation in women with breast cancer. (2016) (44)
Genome-wide association study of germline variants and breast cancer-specific mortality (2019) (44)
Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab (2016) (43)
Childhood hair product use and earlier age at menarche in a racially diverse study population: a pilot study. (2011) (43)
Maternal cigarette smoking during pregnancy and offspring DNA methylation in midlife (2018) (43)
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers. (2011) (42)
Preeclampsia, pregnancy-related hypertension, and breast cancer risk. (2007) (42)
Estrogen Metabolism and Breast Cancer (2006) (42)
Global DNA methylation levels in white blood cell DNA from sisters discordant for breast cancer from the New York site of the Breast Cancer Family Registry (2012) (41)
Alcohol intake over the life course and mammographic density (2009) (41)
Age-specific breast cancer risk by body mass index and familial risk: prospective family study cohort (ProF-SC) (2018) (41)
Residential environmental exposures and other characteristics associated with detectable PAH-DNA adducts in peripheral mononuclear cells in a population-based sample of adult females (2005) (41)
Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). (2020) (40)
40 Years of Change in Age- and Stage-Specific Cancer Incidence Rates in US Women and Men (2019) (40)
Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women (2016) (39)
Changes in mammographic density over time in breast cancer cases and women at high risk for breast cancer (2014) (39)
Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants (2022) (39)
Global DNA methylation levels in girls with and without a family history of breast cancer (2011) (39)
Temporal variation in chlorinated hydrocarbons in healthy women. (1997) (38)
Life course exposure to smoke and early menopause and menopausal transition (2015) (38)
Genetic polymorphisms in alcohol metabolism, alcohol intake and the risk of stomach cancer in Warsaw, Poland (2007) (38)
The effect of calcium and vitamin supplements on the incidence and recurrence of colorectal adenomatous polyps (1996) (37)
XRCC1 polymorphisms and breast cancer risk from the New York Site of the Breast Cancer Family Registry: A family-based case-control study (2010) (37)
Assessing Associations between the AURKA-HMMR-TPX2-TUBG1 Functional Module and Breast Cancer Risk in BRCA1/2 Mutation Carriers (2015) (37)
Gestational diabetes and the risk of breast cancer among women in the Jerusalem Perinatal Study (2008) (37)
Hair product use, age at menarche and mammographic breast density in multiethnic urban women (2018) (37)
Maternal weight gain in excess of pregnancy guidelines is related to daughters being overweight 40 years later. (2016) (37)
Smoking and risk of breast cancer in carriers of mutations in BRCA1 or BRCA2 aged less than 50 years (2008) (36)
Validity of self-reported birth weight by adult women: sociodemographic influences and implications for life-course studies. (2009) (36)
The estimated frequency of cosmetic breast augmentation among US women, 1963 through 1988. (1995) (36)
Correlation of DNA methylation levels in blood and saliva DNA in young girls of the LEGACY Girls study (2014) (36)
Increased incidence of colorectal adenomas in follow-up evaluation of patients with newly diagnosed hyperplastic polyps (2001) (36)
Nonsteroidal Anti-inflammatory Drug Use Associated with Reduced Incidence of Adenocarcinomas of the Esophagus and Gastric Cardia that Overexpress Cyclin D1 (2004) (36)
DNA adducts, DNA repair genotype/phenotype and cancer risk. (2005) (35)
Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers (2020) (35)
Practical Problems With Clinical Guidelines for Breast Cancer Prevention Based on Remaining Lifetime Risk (2015) (35)
Polymorphisms in DNA repair genes, recreational physical activity and breast cancer risk (2014) (34)
Aberrant Methylation of RASSF1A in Plasma DNA Before Breast Cancer Diagnosis in the Breast Cancer Family Registry (2009) (34)
Double-strand breaks repair in lymphoblastoid cell lines from sisters discordant for breast cancer from the New York site of the BCFR. (2008) (34)
Recreational physical activity is associated with reduced breast cancer risk in adult women at high risk for breast cancer: a cohort study of women selected for familial and genetic risk. (2019) (34)
Estrogen-biosynthesis gene CYP17 and its interactions with reproductive, hormonal and lifestyle factors in breast cancer risk: results from the Long Island Breast Cancer Study Project. (2008) (33)
Genetic polymorphisms in telomere pathway genes, telomere length, and breast cancer survival (2012) (33)
Plasma protein carbonyls and breast cancer risk in sisters discordant for breast cancer from the New York site of the Breast Cancer Family Registry. (2009) (33)
C-Reactive Protein and Colorectal Cancer Mortality in U.S. Adults (2014) (33)
Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study (2019) (33)
Breast Cancer Chemoprevention among High‐risk Women and those with Ductal Carcinoma In Situ (2015) (33)
Epigenetic Biomarkers of Breast Cancer Risk: Across the Breast Cancer Prevention Continuum. (2016) (33)
Use of Self-Care and Practitioner-Based Forms of Complementary and Alternative Medicine before and after a Diagnosis of Breast Cancer (2013) (33)
Dietary intake of fish, polyunsaturated fatty acids, and survival after breast cancer: A population‐based follow‐up study on Long Island, New York (2015) (32)
Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus (2016) (32)
microRNA Expression in Prospectively Collected Blood as a Potential Biomarker of Breast Cancer Risk in the BCFR. (2015) (31)
Immunohistochemical analysis of polycyclic aromatic hydrocarbon-DNA adducts in breast tumor tissue. (2000) (31)
Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women. (1999) (30)
Reproductive and menstrual factors and mammographic density in African American, Caribbean, and white women (2011) (30)
Does stage of change modify the effectiveness of an educational intervention to improve diet among family members of hospitalized cardiovascular disease patients? (2010) (30)
No effect of weight loss on LINE‐1 methylation levels in peripheral blood leukocytes from postmenopausal overweight women (2014) (29)
Alcohol dehydrogenase 3 and risk of esophageal and gastric adenocarcinomas (2007) (29)
Prevalence and predictors of antioxidant supplement use during breast cancer treatment (2009) (29)
The use of complete-case and multiple imputation-based analyses in molecular epidemiology studies that assess interaction effects (2011) (27)
Mutation screening of PALB2 in clinically ascertained families from the Breast Cancer Family Registry (2015) (27)
Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk. (2020) (27)
Second primary breast cancer in BRCA1 and BRCA2 mutation carriers: 10-year cumulative incidence in the Breast Cancer Family Registry (2015) (27)
A network analysis to identify mediators of germline-driven differences in breast cancer prognosis (2020) (27)
p53 Gene Expression in Relation to Indoor Exposure to Unvented Coal Smoke in Xuan Wei, China (2001) (27)
The role of birth cohorts in studies of adult health: the New York women's birth cohort. (2009) (26)
Oral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort Study (2018) (26)
The Early Determinants of Adult Health Study (2011) (26)
Alcohol metabolism, alcohol intake, and breast cancer risk: a sister-set analysis using the Breast Cancer Family Registry (2007) (26)
Removal of benzo(a)pyrene diol epoxide (BPDE)‐DNA adducts as a measure of DNA repair capacity in lymphoblastoid cell lines from sisters discordant for breast cancer (2002) (26)
Polycyclic aromatic hydrocarbon (PAH)–DNA adducts and breast cancer: modification by gene promoter methylation in a population-based study (2015) (26)
Pre- and postnatal determinants of childhood body size: cohort and sibling analyses (2011) (26)
Risk-Reducing Oophorectomy and Breast Cancer Risk Across the Spectrum of Familial Risk (2018) (25)
Prenatal smoke exposure and mammographic density in mid-life (2011) (25)
Comparison of Clinical, Maternal, and Self Pubertal Assessments: Implications for Health Studies (2016) (25)
ADH 3 genotype , alcohol intake and breast cancer risk (2006) (25)
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers (2015) (25)
Validation of family cancer history data in high-risk families: the influence of cancer site, ethnicity, kinship degree, and multiple family reporters. (2015) (25)
Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation (2013) (24)
Diagnostic Chest X-Rays and Breast Cancer Risk before Age 50 Years for BRCA1 and BRCA2 Mutation Carriers (2013) (23)
Investigation of the miR16-1 (C > T) + 7 Substitution in Seven Different Types of Cancer from Three Ethnic Groups (2009) (23)
Cigarette smoking and the colorectal adenoma-carcinoma sequence. (2008) (23)
Genomic Methylation Changes Over Time in Peripheral Blood Mononuclear Cell DNA: Differences by Assay Type and Baseline Values (2012) (23)
The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With BRCA1 or BRCA2 Mutations (2018) (23)
Alcohol consumption, cigarette smoking, and familial breast cancer risk: findings from the Prospective Family Study Cohort (ProF-SC) (2019) (23)
A Nonsynonymous Polymorphism in IRS1 Modifies Risk of Developing Breast and Ovarian Cancers in BRCA1 and Ovarian Cancer in BRCA2 Mutation Carriers (2012) (22)
Breast cancer risk variants at 6 q 25 display different phenotype associations and regulate ESR 1 , RMND 1 and CCDC 170 (2016) (22)
Polyunsaturated fatty acid interactions and breast cancer incidence: a population-based case-control study on Long Island, New York. (2015) (22)
Oral contraceptive use and cyclin D1 overexpression in breast cancer among young women. (2002) (22)
Differences in DNA methylation by extent of breast cancer family history in unaffected women (2014) (22)
Early life exposure to cigarette smoke and depressive symptoms among women in midlife. (2014) (22)
The birth cohorts grow up: new opportunities for epidemiology. (2000) (22)
Age at Menopause (2020) (21)
Tobacco, alcohol, and p53 overexpression in early colorectal neoplasia (2003) (21)
The Handling of Missing Data in Molecular Epidemiology Studies (2011) (20)
Mismatch Repair Polymorphisms as Markers of Breast Cancer Prevalence in the Breast Cancer Family Registry. (2016) (20)
Influence of Nativity Status on Breast Cancer Risk Among US Black Women (2006) (20)
The impact of cancer prevention guideline adherence on overall mortality in a high-risk cohort of women from the New York site of the Breast Cancer Family Registry (2015) (20)
Catechol-O-methyltransferase haplotypes and breast cancer among women on Long Island, New York (2006) (20)
Trends in Parity and Breast Cancer Incidence in US Women Younger Than 40 Years From 1935 to 2015 (2020) (20)
Xeroderma pigmentosum complementation group C genotypes/diplotypes play no independent or interaction role with polycyclic aromatic hydrocarbons-DNA adducts for breast cancer risk. (2008) (20)
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer (2019) (20)
Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3 (2016) (20)
Environmental exposures and breast cancer risk in the context of underlying susceptibility: A systematic review of the epidemiological literature. (2020) (19)
Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers (2011) (19)
The LEGACY Girls Study: Growth and Development in the Context of Breast Cancer Family History (2016) (19)
Genetic Variation in Telomere Maintenance Genes, Telomere Length and Breast Cancer Risk (2012) (19)
Interactions among GSTM 1 , GSTT 1 and GSTP 1 polymorphisms , cruciferous vegetable intake and breast cancer risk (2007) (19)
Is breast cancer a result of epigenetic responses to traffic-related air pollution? A review of the latest evidence. (2019) (19)
Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study (2021) (18)
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. (2016) (18)
Applications for Quantile Regression in Epidemiology (2019) (18)
DNA methylation modifies the association between obesity and survival after breast cancer diagnosis (2016) (18)
Earlier age at menarche in girls with rapid early life growth: cohort and within sibling analyses. (2017) (18)
Discordant attitudes and beliefs about cancer clinical trial participation between physicians, research staff, and cancer patients (2020) (18)
Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study. (2018) (17)
A conception-to-death cohort (2003) (17)
The influence of one-carbon metabolism on gene promoter methylation in a population-based breast cancer study (2011) (17)
Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Results from The BRCA1 and BRCA2 Cohort Consortium (2019) (17)
Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer (2010) (17)
Distinct epigenetic profiles in children with perinatally-acquired HIV on antiretroviral therapy (2019) (17)
Nonsteroidal Anti-inflammatory Drugs and Change in Mammographic Density: A Cohort Study Using Pharmacy Records on Over 29,000 Postmenopausal Women (2008) (17)
Pubertal development in girls by breast cancer family history: the LEGACY girls cohort (2017) (17)
Latent class analysis suggests four distinct classes of complementary medicine users among women with breast cancer (2015) (17)
Integrating DNA methylation measures to improve clinical risk assessment: are we there yet? The case of BRCA1 methylation marks to improve clinical risk assessment of breast cancer (2020) (17)
Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2mutation carriers (2012) (16)
Correlations in global DNA methylation measures in peripheral blood mononuclear cells and granulocytes (2014) (16)
Transcriptome-wide association study of breast cancer risk by estrogen-receptor status (2020) (16)
Risk factors for a causal intermediate and an endpoint: reconciling differences. (2000) (16)
Prostate cancer in fathers with fewer male offspring: the Jerusalem Perinatal Study cohort. (2007) (16)
Cigarette smoking and microsatellite instability: causal pathway or marker-defined subset of colon tumors? (2000) (16)
Modification of the association between recreational physical activity and survival after breast cancer by promoter methylation in breast cancer-related genes (2017) (15)
Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers (2019) (15)
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (2021) (15)
In Utero DDT Exposure and Breast Density Before Age 50. (2016) (15)
The metabolic syndrome and mammographic breast density in a racially diverse and predominantly immigrant sample of women (2015) (15)
Generalizability of Polygenic Risk Scores for Breast Cancer Among Women With European, African, and Latinx Ancestry (2021) (15)
Polymorphisms in XRCC 1 Modify the Association between Polycyclic Aromatic Hydrocarbon-DNA Adducts , Cigarette Smoking , Dietary Antioxidants , and Breast Cancer Risk (2005) (15)
Mammographic density and serum 25-hydroxyvitamin D levels (2014) (14)
Risk factors for uncommon histologic subtypes of breast cancer using centralized pathology review in the Breast Cancer Family Registry (2012) (14)
DNA double-strand break repair genotype and phenotype and breast cancer risk within sisters from the New York site of the Breast Cancer Family Registry (BCFR) (2013) (14)
Common Genetic Variants and Modification of Penetrance of BRCA 2-Associated Breast Cancer (2010) (14)
Towards precision prevention: Technologies for identifying healthy individuals with high risk of disease. (2017) (14)
Psychosocial Adjustment in School-age Girls With a Family History of Breast Cancer (2015) (14)
IGHMBP2 Thr671Ala polymorphism might be a modifier for the effects of cigarette smoking and PAH–DNA adducts to breast cancer risk (2006) (13)
Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management Tool (2019) (13)
Risks of Breast, Ovarian, and Contralateral Breast Cancer for $\textit{BRCA1}$ and $\textit{BRCA2}$ Mutation Carriers (2017) (13)
In Utero DDT Exposure and Breast Density in Early Menopause by Maternal History of Breast Cancer. (2020) (13)
DDT exposure during pregnancy and DNA methylation alterations in female offspring in the Child Health and Development Study. (2020) (13)
Age at cancer diagnosis, amenability to medical interventions, and racial/ethnic disparities in cancer mortality (2016) (13)
DNA Repair Gene Expression Levels as Indicators of Breast Cancer in the Breast Cancer Family Registry. (2016) (13)
Multiple metabolic risk factors and mammographic breast density. (2014) (12)
Racial and gender discrimination, early life factors, and chronic physical health conditions in midlife. (2014) (12)
Gene-Specific Promoter Methylation Status in Hormone-Receptor-Positive Breast Cancer Associates with Postmenopausal Body Size and Recreational Physical Activity. (2015) (12)
Alcohol consumption and serum hormone levels during pregnancy. (2005) (12)
Relationship between Urinary 15F 2 t-Isoprostane and 8-Oxodeoxyguanosine Levels and Breast Cancer Risk (2006) (12)
Inflammatory Biomarkers and Breast Cancer Risk: A Systematic Review of the Evidence and Future Potential for Intervention Research (2020) (12)
Non-invasive optical spectroscopic monitoring of breast development during puberty (2017) (12)
Association of Risk-Reducing Salpingo-Oophorectomy With Breast Cancer Risk in Women With BRCA1 and BRCA2 Pathogenic Variants. (2021) (11)
Assessing the goodness of fit of personal risk models (2014) (11)
Contribution of large genomic BRCA1 alterations to early-onset breast cancer selected for family history and tumour morphology: a report from The Breast Cancer Family Registry (2011) (11)
Prediagnosis aspirin use, DNA methylation, and mortality after breast cancer: A population‐based study (2019) (11)
Abortion and the risk of breast cancer. Is there a believable association? (1996) (11)
Prostate Cancer in Fathers With Fewer Male Offspring: the Jerusalem Perinatal Study Cohort (2007) (11)
Early life growth, socioeconomic status, and mammographic breast density in an urban US birth cohort. (2016) (11)
Biomarkers of Aging in HIV-Infected Children on Suppressive Antiretroviral Therapy (2018) (11)
Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (11)
Oral contraceptive and reproductive risk factors for ovarian cancer within sisters in the breast cancer family registry (2014) (11)
Alcohol consumption and breast cancer-specific and all-cause mortality in women diagnosed with breast cancer at the New York site of the Breast Cancer Family Registry (2017) (11)
Total energy intake and breast cancer risk in sisters: the Breast Cancer Family Registry (2012) (11)
Consistency, now what? (2017) (10)
The characteristics and training of professionals in cancer prevention and control: a survey of theAmerican Society for Preventive Oncology. (2004) (10)
Infection and pubertal timing: a systematic review. (2016) (10)
Assessing absolute changes in breast cancer risk due to modifiable risk factors (2015) (10)
Prenatal Tobacco Smoke Exposure and Genomewide Methylation in Adulthood (2011) (10)
Alcohol intake from early adulthood to midlife and mammographic density (2016) (10)
Temporal Trends in Tuberculosis Hospitalization Rates Before and After Implementation of Directly Observed Therapy: New York City, 1988–1995 (2002) (9)
Assessing patient readiness for personalized genomic medicine (2018) (9)
Benign breast disease increases breast cancer risk independent of underlying familial risk profile: Findings from a Prospective Family Study Cohort (2019) (9)
Prenatal polycyclic aromatic hydrocarbons, altered ERα pathway-related methylation and expression, and mammary epithelial cell proliferation in offspring and grandoffspring adult mice. (2021) (9)
Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers (2016) (9)
Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes (2019) (9)
Mortality after breast cancer as a function of time since diagnosis by estrogen receptor status and age at diagnosis (2019) (9)
Pre-Pubertal Internalizing Symptoms and Timing of Puberty Onset in Girls. (2020) (9)
Empowering Pediatricians to Prevent Chronic Disease Across Generations (2016) (9)
Bilateral Salpingo-Oophorectomy to Reduce Breast Cancer Risk in Women With Germline BRCA1 or BRCA2 Pathogenic Variants-Caution Needed-Reply. (2021) (9)
Recruiting and Training Leadership through Professional Societies: A Report from the American Society of Preventive Oncology Junior Members Interest Group (2006) (9)
Validation of the IBIS breast cancer risk evaluator for women with lobular carcinoma in-situ (2018) (8)
Prospective Evaluation of the Addition of Polygenic Risk Scores to Breast Cancer Risk Models (2021) (8)
Controversies in Communication of Genetic Screening Results for Cancer: A Report from the American Society of Preventive Oncology's Screening Special Interest Group (ASPO's 33rd Annual Meeting, March 8 to 10, 2009, Tampa, Florida) (2010) (8)
Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D Supplementation in Premenopausal Women at High Risk for Breast Cancer (SWOG S0812) (2019) (8)
Breast cancer family history and allele-specific DNA methylation in the legacy girls study (2018) (8)
Maternal and Early Childhood Determinants of Women's Body Size in Midlife: Overall Cohort and Sibling Analyses (2017) (8)
Circulating growth factor concentrations and breast cancer risk: a nested case-control study of IGF-1, IGFBP-3, and breast cancer in a family-based cohort (2020) (8)
Pre-diagnostic aspirin use and mortality after breast cancer (2018) (8)
Nonsteroidal Anti-inflammatory Drug Use Associated with Reduced Incidence of Adenocarcinomas of the Esophagus and Gastric Cardia that Overexpress Cyclin D1: A Population-Based Study (2004) (8)
Why do studies show different associations between intrauterine exposure to maternal smoking and age at menarche? (2018) (8)
Early life socioeconomic environment and mammographic breast density (2017) (7)
Comparing Five-Year and Lifetime Risks of Breast Cancer in the Prospective Family Study Cohort. (2020) (7)
Racial and ethnic differences in adjuvant hormonal therapy use. (2012) (7)
Associations of prenatal exposure to polycyclic aromatic hydrocarbons with pubertal timing and body composition in adolescent girls: Implications for breast cancer risk. (2020) (7)
Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants. (2022) (7)
Hormone replacement therapy and breast cancer risk: more evidence for risk stratification? (2013) (7)
DNA Methylation in Breast Tumor from High-risk Women in the Breast Cancer Family Registry. (2017) (7)
Sex, age, and race/ethnicity do not modify the effectiveness of a diet intervention among family members of hospitalized cardiovascular disease patients. (2011) (7)
Study protocol: Randomized controlled trial of web-based decision support tools for high-risk women and healthcare providers to increase breast cancer chemoprevention (2019) (7)
Genetic variation in multiple biologic pathways, flavonoid intake, and breast cancer (2014) (7)
Global DNA Methylation, Measured by the Luminometric Methylation Assay (LUMA), Associates with Postmenopausal Breast Cancer in Non-Obese and Physically Active Women (2015) (7)
DNA methylation and cancer incidence: lymphatic–hematopoietic versus solid cancers in the Strong Heart Study (2021) (6)
Reproductive characteristics are associated with gene-specific promoter methylation status in breast cancer (2019) (6)
Nonsteroidal Anti-inflammatory Drug Use Associated with Reduced Incidence of Adenocarcinomas of the Esophagus and Gastric Cardia that Overexpress Cyclin D 1 : A Population-Based Study (2004) (6)
Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element (2021) (6)
Germline Variation and Breast Cancer Incidence: A Gene-Based Association Study and Whole-Genome Prediction of Early-Onset Breast Cancer (2018) (6)
Family-based Breast Cancer Prevention Efforts in Adolescence (2016) (6)
Common breast cancer risk loci predispose to distinct tumor subtypes (2019) (6)
Potential Intervention Targets in Utero and Early Life for Prevention of Hormone Related Cancers (2016) (6)
Community education to enhance the more equitable use of precision medicine in Northern Manhattan (2020) (6)
Common variants in breast cancer risk loci predispose to distinct tumor subtypes (2022) (6)
Re: "p53 protein overexpression in relation to risk factors for breast cancer". (1998) (6)
Cancer Risk Reduction Through Education of Adolescents: Development of a Tailored Cancer Risk-Reduction Educational Tool (2021) (5)
Age-specific trends in colorectal cancer incidence for women and men, 1935-2017. (2021) (5)
Symptoms and demographic factors associated with early-onset colorectal neoplasia among individuals undergoing diagnostic colonoscopy (2020) (5)
Fertility Drug Use and Mammographic Breast Density in a Mammography Screening Cohort of Premenopausal Women (2008) (5)
Independent and joint cross-sectional associations of statin and metformin use with mammographic breast density (2020) (5)
Genetic polymorphisms in DNA repair and oxidative stress pathways may modify the association between body size and postmenopausal breast cancer. (2015) (5)
Human subjects protection: an event monitoring committee for research studies of girls from breast cancer families. (2014) (5)
Atypical hyperplasia of the breast. (2015) (5)
Erratum: MGMT genotype modulates the associations between cigarette smoking, dietary antioxidants and breast cancer risk (Carcinogenesis (2005) vol. 26 (12) (2131-2137) 10.1093/carcin/bgi179) (2007) (5)
Early-life Growth and Benign Breast Disease. (2019) (5)
Association of Prepubertal and Adolescent Androgen Concentrations With Timing of Breast Development and Family History of Breast Cancer (2019) (5)
Maternal Anthropometry and Mammographic Density in Adult Daughters (2016) (5)
Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer (2010) (5)
Re: "Quantile regression—opportunities and challenges from a user's perspective". (2015) (5)
Long-term PM2.5 exposure before diagnosis is associated with worse outcome in breast cancer (2021) (5)
Symposium report: breast cancer in India—trends, environmental exposures and clinical implications (2021) (5)
Abortion and the risk of breast cancer: A case‐control study in Greece (1995) (5)
Antidepressant Medications and Change in Mammographic Density in Postmenopausal Women (2009) (5)
Prospective Evaluation over 15 Years of Six Breast Cancer Risk Models (2021) (4)
Environmental Influences on Mammographic Breast Density in California: A Strategy to Reduce Breast Cancer Risk (2019) (4)
Menopausal hormone therapy use and long‐term all‐cause and cause‐specific mortality in the Long Island Breast Cancer Study Project (2020) (4)
A Clinical Risk Model for Surgical Site Infection Following Pediatric Spine Deformity Surgery (2021) (4)
Testing for Gene-Environment Interactions Using a Prospective Family Cohort Design: Body Mass Index in Early and Later Adulthood and Risk of Breast Cancer (2017) (4)
Body size at birth, early-life growth and the timing of the menopausal transition and natural menopause. (2020) (4)
Birth weight and breast cancer. (2005) (4)
Incidence rate of breast cancer in young women. (2013) (4)
Associations of Nativity, Age at Migration, and Percent of Life in the U.S. with Midlife Body Mass Index and Waist Size in New York City Latinas (2020) (4)
Publisher Correction: Shared heritability and functional enrichment across six solid cancers (2019) (4)
Effects of fertility on breast cancer incidence trends: comparing France and US (2021) (4)
Limited influence of germline genetic variation on all-cause mortality in women with early onset breast cancer: evidence from gene-based tests, single-marker regression, and whole-genome prediction (2017) (4)
Do Birth Weight and Weight Gain During Infancy and Early Childhood Explain Variation in Mammographic Density in Women in Midlife? Results From Cohort and Sibling Analyses (2018) (4)
Acculturation and Ethnic Variations in Breast Cancer Risk Factors, Gail Model Risk Estimates and Mammographic Breast Density (2015) (4)
Childhood body size and midlife mammographic breast density in foreign-born and U.S.-born women in New York City. (2018) (4)
Commentary: towards a definite coherent heterogeneity in meta-analyses. (2014) (4)
Analysis of the breast cancer methylome using formalin-fixed paraffin-embedded tumour (2016) (4)
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment (2021) (3)
Cigarette Smoking and Other Risk Factors in Relation to p 53 Expression in Breast Cancer among Young Women 1 (1999) (3)
Improvement on recovery and reproducibility for quantifying urinary mono-hydroxylated polycyclic aromatic hydrocarbons (OH-PAHs). (2022) (3)
The Steroid Metabolome and Breast Cancer Risk in Women with a Family History of Breast Cancer: The Novel Role of Adrenal Androgens and Glucocorticoids (2020) (3)
Terry et al. Respond to “Antecedents of Obesity” (2007) (3)
Reproductive and environmental exposures and the breast cancer risk in Taiwanese women (2021) (3)
E-cigarette Use Among Young Adult Patients: The Opportunity to Intervene on Risky Lifestyle Behaviors to Reduce Cancer Risk (2021) (3)
DNA repair phenotype and cancer risk: a systematic review and meta-analysis of 55 case–control studies (2022) (3)
Performance of BCRAT in high-risk patients with breast cancer - Authors' reply. (2019) (3)
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk (2020) (3)
Alcohol, Binge Drinking, and Cancer Risk: Accelerating Public Health Messaging Through Countermarketing. (2021) (3)
Mendelian randomisation study of smoking exposure in relation to breast cancer risk (2021) (3)
Do current family history-based genetic testing guidelines contribute to breast cancer health inequities? (2022) (3)
Influence of pubertal development on urinary oxidative stress biomarkers in adolescent girls in the New York LEGACY cohort (2020) (3)
Age-Specific Indicators of a Healthy Lifestyle and Postmenopausal Breast Cancer. (2017) (3)
Comparison of methods to assess onset of breast development in the LEGACY Girls Study: methodological considerations for studies of breast cancer (2018) (3)
Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study (2019) (3)
Breast Density Awareness and Knowledge in a Mammography Screening Cohort of Predominantly Hispanic Women: Does Breast Density Notification Matter? (2021) (3)
P4-11-06: Uptake of Selective Estrogen Receptor Modulators and Other Breast Cancer Prevention Strategies among High-Risk Women Seen in a Breast Center. (2011) (2)
Considerations when using breast cancer risk models for women with negative BRCA1/BRCA2 mutation results. (2020) (2)
Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits (2022) (2)
Non-invasive optical spectroscopic monitoring of breast development during puberty (2017) (2)
Alcohol consumption, cigarette smoking, and familial breast cancer risk: findings from the Prospective Family Study Cohort (ProF-SC) (2019) (2)
Terry and Colleagues Respond (1996) (2)
Oral Contraceptive Use and Cyclin D 1 Overexpression in Breast Cancer among Young Women (2002) (2)
Hair Product Use and Mammographic Density (2009) (2)
#108-S tracking of a subcohort of the national collaborative perinatal project (2002) (2)
Randomized double-blind placebo-controlled biomarker modulation study of vitamin d in premenopausal women at high risk for breast cancer (SWOG S0812). (2018) (2)
Oral Contraceptive Use and Parity Associations with Uncommon Breast Cancer Histologies in the Breast Cancer Family Registry: the Role of Family History (2011) (2)
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study (2022) (2)
Using time-varying quantile regression approaches to model the influence of prenatal and infant exposures on childhood growth (2017) (2)
Editorial: Perspectives in Primary Prevention Research for Breast Cancer: A Focus on Gene—Environment Interactions (2020) (2)
STROBE-ME - illuminating methodological issues for the reporting of molecular epidemiology data. (2011) (2)
Placental Morphometry in Relation to Daughters' Percent Mammographic Breast Density at Midlife. (2019) (2)
Risk Factors for Advanced Colorectal Adenomas (2002) (2)
Commentary: No multiplicative GXE interactions for breast cancer risk: Have we reached a verdict or is the jury still out? (2019) (2)
Less Is More—Ways to Move Forward for Improved Breast Cancer Risk Stratification (2021) (2)
Two truncating variants in FANCC and breast cancer risk (2019) (2)
PDK 1 potentiates upstream lesions on the PI 3 K pathway in breast carcinoma (2009) (2)
Response to ten Broeke et al. (2018) (2)
Predictors of urinary polycyclic aromatic hydrocarbon metabolites in girls from the San Francisco Bay Area (2021) (2)
Dependence of cancer risk from environmental exposures on underlying genetic susceptibility: an illustration with polycyclic aromatic hydrocarbons and breast cancer (2017) (1)
Benign breast disease and changes in mammographic breast density (2021) (1)
Recreational Physical Activity and Outcomes After Breast Cancer in Women at High Familial Risk (2021) (1)
Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women (2016) (1)
Breast Tissue Composition—Why It Matters and How Can We Measure It More Accurately in Epidemiology Studies (2021) (1)
SERUM DDT IN MOTHERS AND EARLY MENOPAUSE IN DAUGHTERS : A FIFTY YEAR FOLLOW- UP OF THE CHILD HEALTH AND DEVELOPMENT STUDIES PREGNANCY COHORT (2011) (1)
Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in $\small \textit{BRCA1}$ and $\small \textit{BRCA2}$ Mutation Carriers (2016) (1)
Cancer Risk Reduction Through Education of Adolescents: Development of a Tailored Cancer Risk-Reduction Educational Tool (2021) (1)
Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (1)
Response to Evans et al. (2018) (1)
Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care (2022) (1)
Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk (2014) (1)
Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance (2012) (1)
A comparison of various methods for measuring breast density and breast tissue composition in adolescent girls and women (2022) (1)
Age-specific breast cancer risk by body mass index and familial risk: prospective family study cohort (ProF-SC) (2018) (1)
Abstract B98: Parity, breastfeeding and oral contraceptive use and risk of estrogen- and progesterone-negative breast cancer in the Breast Cancer Family Registry (2012) (1)
Identiﬁcation of four novel susceptibility loci for oestrogen receptor negative breast cancer (2016) (1)
Validation of the IBIS breast cancer risk evaluator for women with lobular carcinoma in-situ (2018) (1)
Polygenic Risk Modelling for Prediction of Epithelial Ovarian Cancer Risk (2020) (1)
Abstract 4276: Oral contraceptive use and breast cancer risk: a cohort study ofBRCA1andBRCA2mutation carriers (2017) (1)
Breast cancer worry, uncertainty, and perceived risk following breast density notification in a longitudinal mammography screening cohort (2022) (1)
Dietary factors and early-onset colorectal cancer in the United States-an ecologic analysis. (2022) (1)
Reducing Breast Cancer Risk Across Generations Through Family-Based Interventions (2020) (1)
Common Childhood Viruses and Pubertal Timing: The LEGACY Girls Study. (2020) (1)
phylogenetic approach identified mitochondrial haplogroup T 1 a 1 as inversely associated with breast cancer risk in BRCA 2 mutation carriers (2015) (1)
A competing risks model with binary time varying covariates for estimation of breast cancer risks in BRCA1 families (2021) (1)
Accuracy of Self‐Report of Breast Implants (1998) (1)
Exposure to polycyclic aromatic hydrocarbons during pregnancy and breast tissue composition in adolescent daughters and their mothers: a prospective cohort study (2022) (1)
Survival model methods for analyses of cancer incidence trends in young adults (2020) (1)
Response to Lee et al 2019: Essential to frame study implications within the context of prior findings from enriched cohorts for underlying familial risk of breast cancer (2019) (1)
Differences in Mammographic Density Decline over Time in Breast Cancer Cases and Women at High Risk for Breast Cancer (2013) (1)
Mother and Daughter Perspectives on Genetic Counseling and Testing of Adolescents for Hereditary Breast Cancer Risk. (2022) (1)
Title Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA 1 and BRCA 2 mutation carriers (2015) (1)
Abstract P4-09-02: Validation of iPrevent using the prospective family study cohort (ProF-SC) (2019) (1)
Reassessing the causal role of early-life adiposity in breast cancer: could the apparent inverse associations be a manifestation of survival bias? (2023) (1)
Polymorphism in the trifunctional enzyme coding gene MTHFD1 and the risk of stomach cancer (2006) (1)
6 Epigenetic dysregulation of the major histocompatibility complex (MHC) region in HIV-infected children on early antiretroviral therapy (2017) (1)
Translate but validate: necessary steps in improving the use and utility of cancer risk models (2020) (1)
Feasibility of collecting tumor samples of breast cancer patients diagnosed up to 50 years ago in the Child Health and Development Studies (2017) (1)
A network analysis to identify mediators of germline-driven differences in breast cancer prognosis (2020) (1)
University of Groningen Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA 1 and BRCA 2 Mutation Carriers (2017) (1)
Interaction between polyunsaturated fatty acids and genetic variants in relation to breast cancer incidence. (2016) (1)
No Association Between Glutathione Peroxidase Pro 198 Leu Polymorphism and Breast Cancer Risk (2005) (1)
Abstract P6-10-17: Psychosocial adjustment, cancer worry and perceived risk in 6-13 year old girls from breast cancer families (2015) (1)
Erratum: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: An international prospective cohort of BRCA1 and BRCA2 mutation carriers (Breast Cancer Res (2020) 22 (8) DOI: 10.1186/s13058-020-1247-4) (2020) (1)
Rare germline copy number variants (CNVs) and breast cancer risk (2022) (1)
Air Pollution and Breast Cancer: An Examination of Modification By Underlying Familial Breast Cancer Risk (2021) (1)
Genome-wide association study of germline variants and breast cancer-speci fi c mortality (2019) (1)
Comparing 5-Year and Lifetime Risks of Breast Cancer using the Prospective Family Study Cohort (2021) (1)
OP-JNCI190195 418..422 (2020) (0)
Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia (2014) (0)
Response to Wang et al. (2019) (0)
Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation (2013) (0)
DEMOGRAPHIC AND LIFESTYLE FACTORS AFFECTING GENOMIC BLOOD DNA METHYLATION BIOMARKER LEVELS (2011) (0)
Modification of the association between recreational physical activity and survival after breast cancer by promoter methylation in breast cancer-related genes (2017) (0)
Women's thoughts on receiving and sharing genetic information: Considerations for genetic counseling (2022) (0)
Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers (2020) (0)
Abstract A17: In utero DDT exposure and breast density in early menopause by maternal history of breast cancer (2020) (0)
Abstract 264: Breast cancer incidence and Gail risk in a prospective study of women with benign breast disease (2014) (0)
RE: "GROWTH TRAJECTORIES, BREAST SIZE, AND BREAST-TISSUE COMPOSITION IN A BRITISH PREBIRTH COHORT OF YOUNG WOMEN". (2018) (0)
Abstract A07: Lifestyle modifications and use of complementary and alternative medicine in relation to perceived and model-based breast cancer risk among women at high risk of developing breast cancer (2012) (0)
Abstract 2555: Promoter DNA methylation patterns in breast tumor and matched adjacent non-tumor tissues in the breast cancer family registry (2016) (0)
Correction to: Current regular aspirin use and mammographic breast density: a cross-sectional analysis considering concurrent statin and metformin use (2022) (0)
OP-JNCI180212 331..334 (2019) (0)
Abstract 3835: DNA methylation levels in mononuclear DNA in breast cancer from the New York site of the BCFR (2015) (0)
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers (2015) (0)
Do Temporal Trends in Cancer Incidence Reveal Organ System Connections for Cancer Etiology? (2020) (0)
Assessing patient readiness for personalized genomic medicine (2018) (0)
Collection of Biostatistics Research Archive (2010) (0)
Air pollution and breast cancer: an examination of modification by familial breast cancer risk (2021) (0)
Genetic–epigenetic interactions in cis: a major focus in the post-GWAS era (2017) (0)
Abstract P5-15-02: Withdrawn (2018) (0)
Interest in genetic testing and risk-reducing behavioral changes: results from a community health assessment in New York City (2022) (0)
Common variants in breast cancer risk loci predispose to distinct tumor subtypes (2022) (0)
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers (2014) (0)
Abstract P6-09-01: Risk-reducing oophorectomy and breast cancer risk across the spectrum of familial risk using a prospective family study cohort (ProF-SC) (2018) (0)
Distinct epigenetic profiles in children with perinatally-acquired HIV on antiretroviral therapy (2019) (0)
Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (0)
DNA Damage and Repair and Cancer Risk: A Systematic Review and Meta-Analysis of 55 Case- Control Studies (2021) (0)
Abstract P3-03-21: Biological and Cultural Drivers of Early-Onset Breast Cancer: a mixed-method study (2023) (0)
Abstract P4-03-26: Blood DNA Methylation and Breast Cancer: a Prospective Case-Control Analysis in the Breast Cancer Prospective Family Study Cohort (2023) (0)
Prenatal Exposure to Polybrominated Diphenyl Ethers (PBDEs) Flame Retardants and Breast Tissue Composition among Adolescents Girls (2020) (0)
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer (2018) (0)
Abstract P6-09-04: Benign breast disease and breast cancer risk across the spectrum of familial risk using a prospective family study cohort (ProF-SC) (2018) (0)
Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (0)
Abstract P1-08-04: Sources of polycyclic aromatic hydrocarbons associated with gene-specific promoter methylation in women with breast cancer (2016) (0)
Response to Wang et al. (2019) (0)
Abstract P3-09-06: Predicting cardiovascular versus cancer mortality in a cohort of breast cancer survivors (2018) (0)
High-throughput measurement of double strand break (DSB) global repair phenotype in peripheral blood mononuclear cells after long-term cryopreservation. (2023) (0)
Abstract P2-06-01: Non-genetic risk factors improve accuracy of breast cancer risk assessment for women at high familial risk: Comparison of risk estimation models using the prospective family study cohort (ProF-SC) (2017) (0)
P1-33 Adult DNA methylation in relation to prenatal nutrition and risk factors for cardio-vascular disease (2011) (0)
Abstract B011: Breast cancer worry, uncertainty, and perceived risk following breast density notification in a longitudinal mammography screening cohort vary by educational attainment and dominant language (2023) (0)
University of Groningen Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk Couch, (2013) (0)
Age at cancer diagnosis, amenability to medical interventions, and racial/ethnic disparities in cancer mortality (2016) (0)
Tamoxifen and risk of contralateral breast cancer for \textitBRCA1 and \textitBRCA2 mutation carriers (2013) (0)
MSH6 and PMS2 germ-line pathogenic variants implicated in Lynch syndrome are associated with breast cancer (2018) (0)
Abstract 687: Variations in promoter methylation levels of DNA repair genes and breast cancer risk in the New York site of the Breast Cancer Family Registry. (2013) (0)
Pre-proof In Utero DDT Exposure and Breast Density in Early Menopause by Maternal History of Breast Cancer (2019) (0)
Urinary Estrogen Metabolites and Long-Term Mortality Following Breast Cancer (2020) (0)
Abstract 1866: Polymorphisms in DNA double-strand break repair genes and end-joining capacity from sisters discordant for breast cancer from the New York site of the BCFR (2010) (0)
Abstract A15: Prenatal exposure to polycyclic aromatic hydrocarbons and breast tissue composition in adolescent girls (2020) (0)
Weight is More Informative than Body Mass Index for Predicting Postmenopausal Breast Cancer Risk: Prospective Family Study Cohort (ProF-SC) (2021) (0)
Modeling risks of cardiovascular and cancer mortality following a diagnosis of loco-regional breast cancer (2021) (0)
Urinary Biomarkers of Polycyclic Aromatic Hydrocarbons and Timing of Pubertal Development: The California PAH Study (2022) (0)
Response to ten Broeke et al. (2018) (0)
Abstract PR-02: Breast Cancer Risk Assessment: Genetic and Non-Genetic Risk Factors contributing to Differential Model Performance (2012) (0)
Genome-wide association study of germline variants and breast cancer-speci ﬁ c mortality (2019) (0)
197-S: Socioeconomic Status and Age at Menarche Among a Racially Diverse Population of New York Girls (2005) (0)
Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (2021) (0)
Early Life Factors and Breast Cancer Risk (2003) (0)
Cancer Education Interventions for Adolescents: A Systematic Review of Structure, Content, and Effectiveness (2020) (0)
Oral Contraceptive Use and Other Risk Factors in Relation to HER-2 / neu Overexpression in Breast Cancer Among Young Women 1 (1999) (0)
Nsaids and Mammographic Density (2006) (0)
Gender, Age and Race/Ethnicity do not Modify the Effectiveness of a Diet Intervention among Family Members of Hospitalized Cardiovascular Disease Patients (2011) (0)
Abstract ES8-3: Does breast cancer prevention need an 18th amendment? New evidence on alcohol and breast cancer (2019) (0)
Abstract PR07: Comparison of risk model recommendations for women at high-risk of breast cancer based on clinical thresholds using the Prospective Family Study Cohort (ProF-SC) (2017) (0)
Author ' s response to reviews Tobacco , Alcohol , and p 53 Overexpression in Early Colorectal Neoplasia (2003) (0)
Risk Factors for Uncommon Breast Cancer Histologic Types (2012) (0)
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer (2019) (0)
Antimüllerian hormone in prepubescent and adolescent girls (2016) (0)
Abstract PD6-05: Withdrawn (2019) (0)
Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2 (2016) (0)
Modeling risks of cardiovascular and cancer mortality following a diagnosis of loco-regional breast cancer (2021) (0)
Abstract 21: Variations in DNA repair gene expression and breast cancer risk in the New York site of the Breast Cancer Family Registry. (2012) (0)
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes (2020) (0)
Genetic Polymorphisms in Folate Metabolism and Stomach Cancer Risk: A Comparison Between Conventional and Hierarchical Modeling Approaches (2006) (0)
The association of alcohol consumption with mammographic density in a multiethnic urban population (2015) (0)
Abstract P3-08-04: Aspirin and breast cancer risk for BRCA1 and BRCA2 mutation carriers (2015) (0)
Alcohol intake from early adulthood to midlife and mammographic density (2016) (0)
DNA double-strand break repair genotype and phenotype and breast cancer risk within sisters from the New York site of the Breast Cancer Family Registry (BCFR) (2013) (0)
Genome-wide association study of germline variants and breast cancer-specific mortality (2019) (0)
Mo1007 – Identification of Risk Factors for Early Onset Colorectal Neoplasia; a Single-Center, Retrospective Cohort Study of Individuals Younger Than 50 Years Undergoing Diagnostic Colonoscopy (2019) (0)
Consistency, now what? (2017) (0)
Maternal and prenatal factors and age at thelarche in the LEGACY Girls Study cohort: implications for breast cancer risk. (2022) (0)
BRCA1 and BRCA2 mutation carrier predictions using the BRCAPRO model in clinic-based minority families enrolled in the Breast Cancer Family Registry (B-CFR) (2007) (0)
THE ASSOCIATION OF LOBULAR BREAST CANCER WITH GERMLINE MUTATIONS OF CDH1 (2008) (0)
Lack of Male Offspring as a Risk Factor for Prostate Cancer in the Jerusalem Cohort (2006) (0)
Abstract 2271:DNMT1expression is peripheral mononuclear cells is associated with increased breast cancer risk (2017) (0)
Rare copy number variants (CNVs) and breast cancer risk (2021) (0)
595-S: Effects of Childhood Socioeconomic Status on Adult Body Size in Women (2005) (0)
Generalizability of Polygenic Risk Scores for Breast Cancer in the Multiethnic eMERGE Study (2020) (0)
The use of multiple imputation in molecular epidemiologic studies assessing interaction effects (2010) (0)
Benign breast disease and changes in mammographic breast density (2021) (0)
Circulating growth factor concentrations and breast cancer risk: a nested case-control study of IGF-1, IGFBP-3, and breast cancer in a family-based cohort (2020) (0)
Abstract 2830: Energy balance and breast cancer risk among sisters pairs in the Breast Cancer Family Registry Study (2010) (0)
Abstract 886: Genetic polymorphisms in telomere pathway genes may potentially impact breast cancer survival (2010) (0)
Erratum to: Exposure to polychlorinated biphenyl (PCB) congeners measured shortly after giving birth and subsequent risk of maternal breast cancer before age 50 (2016) (0)
Experience of a National Cancer Institute-Designated Community Outreach and Engagement Program in Supporting Communities During the COVID-19 Pandemic (2022) (0)
Diet Quality and All-Cause Mortality in Women with Breast Cancer from the Breast Cancer Family Registry. (2022) (0)
Comparison of attitudes and beliefs about cancer clinical trial enrollment between physicians, research staff, and cancer patients. (2019) (0)
Abstract P5-13-01: Uptake of breast cancer chemoprevention among high-risk women and those with ductal carcinoma in situ. (2013) (0)
q 31 . 2 and in ZNF 365 are associated with breast cancer risk for BRCA 1 and / or BRCA 2 mutation carriers (2012) (0)
Abstract B132: Risk factors for uncommon histologically defined subgroups of breast cancer using the Breast Cancer Family Registry (2010) (0)
Reproductive characteristics are associated with gene-specific promoter methylation status in breast cancer (2019) (0)
Abstract 2778: Association between mammographic density and serum 25-hydroxyvitamin D levels (2010) (0)
Early life socioeconomic environment and mammographic breast density (2017) (0)
The importance of epigenetic gene silencing to the progression of cancer-chromatin events involved (2005) (0)
Abstract C082: Prenatal exposure to polycyclic aromatic hydrocarbons and altered DNA methylation in breast cancer-related genes (2020) (0)
561: Rate of Growth in Early Life, Age at Menarche, and Adult Body Size (2005) (0)
RE: "POPULATION ATTRIBUTABLE FRACTION ESTIMATION FOR ESTABUSHED BREAST CANCER RISK FA C- TORS: CONSIDERING THE ISSUES OF HIGH PREVALENCE AND UNMODIFIABIUTY" (1999) (0)
Pubertal development in girls by breast cancer family history: the LEGACY girls cohort (2017) (0)
Current regular aspirin use and mammographic breast density: a cross-sectional analysis considering concurrent statin and metformin use (2022) (0)
The metabolic syndrome and mammographic breast density in a racially diverse and predominantly immigrant sample of women (2015) (0)
University of Groningen DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers Osorio, (2014) (0)
Abstract B04: Development and comparison of 12-week and 4-week dietary interventions among Hispanic breast cancer survivors (2014) (0)
The Epidemiology of Pregnancy-Related Breast Cancers: Are We Ready to Deliver? (2022) (0)
Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (0)
Organochlorine residues and breast cancer. (1998) (0)
Comparison of methods to assess onset of breast development in the LEGACY Girls Study: methodological considerations for studies of breast cancer (2018) (0)
Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (0)
Abstract P5-08-05: Prospective family cohort analyses of gene-environment interactions in breast cancer: Body mass index (2017) (0)
RE: Selection and Recall Bias in a Case-Control Study of Lifetime Alcohol Intake and Breast Cancer Risk (2006) (0)
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses (2020) (0)
Preeclampsia and Cancer Risk (2017) (0)
Abstract P5-08-09: Use of oral contraceptives and risk of breast cancer inBRCA1andBRCA2mutation carriers: An international prospective cohort study; for the studies of EMBRACE, GENEPSO, HEBON, kConFab and BCFR (2017) (0)
DNA methylation and cancer incidence: lymphatic–hematopoietic versus solid cancers in the Strong Heart Study (2021) (0)
XPC genotypes/diplotypes play no independent or interaction role with PAH-DNA adducts for breast cancer risk (2008) (0)
Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia | NOVA. The University of Newcastle's Digital Repository (2014) (0)
Gestational Diabetes as a Risk Factor for Pancreatic Cancer: The Jerusalem Perinatal Study Cohort (2006) (0)
Genetic variation in multiple biologic pathways, flavonoid intake, and breast cancer (2013) (0)
A Competing Risks Model with Time Varying Covariates for Estimation of Breast Cancer Risks in BRCA1 Families (2020) (0)
Immigrant Generation Status and its Association with Pubertal Timing and Tempo Among Hispanic Girls and Boys (2021) (0)
Abstract 4623: External validation of the BOADICEA model for predicting ovarian cancer risk: The Breast Cancer Family Registry (2020) (0)
Environmental exposures during windows of susceptibility for breast cancer: a framework for prevention research (2019) (0)
Abstract A14: Infancy and childhood infections and pubertal timing in the LEGACY Girls’ Study (2020) (0)
DNA repair capacity via removal of benzo[a]pyrene diolepoxide (BPDE)-DNA adducts in lymphoblastoid cell lines from sisters discordant for breast cancer (2004) (0)
Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer (2019) (0)
Lifecourse socioeconomic conditions and mammographic breast density in African American, Hispanic, and white women (2007) (0)
Translate but validate: necessary steps in improving the use and utility of cancer risk models (2020) (0)
Is it ‘cancer prevention’ or ‘risk reduction’? #Wordsmatter (2021) (0)
Evidence-Based Interventions for Reducing Breast Cancer Disparities: What Works and Where the Gaps Are? (2022) (0)
Correlation between risk benefit index and uptake of breast cancer chemoprevention. (2014) (0)
Issue Information (2022) (0)
Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus (2016) (0)
ful ones, recommendation for its regular use must always be made with full consideration of its risks and benefits and with respect to the patient's health profile. (2017) (0)
Environmental exposures during windows of susceptibility for breast cancer: a framework for prevention research (2019) (0)
Response to Evans et al. (2018) (0)
Polycyclic aromatic hydrocarbon (PAH)–DNA adducts and breast cancer: modification by gene promoter methylation in a population-based study (2015) (0)
Association of breast cancer risk in BRCA 1 and BRCA 2 mutation carriers with genetic variants showing differential allelic expression (2016) (0)
Independent and joint cross-sectional associations of statin and metformin use with mammographic breast density (2020) (0)
Supplemental antioxidant intake and plasma protein carbonyl concentrations in the Long Island Breast Cancer Study Project (2007) (0)
Pre-diagnostic aspirin use and mortality after breast cancer (2018) (0)
Dietary Intake of Isoflavone and All‐Cause Mortality in Women with Breast Cancer: the Breast Cancer Family Registry (2016) (0)
Body mass index rebound and pubertal timing in girls with and without a family history of breast cancer: the LEGACY girls study. (2022) (0)
Abstract P6-10-15: Association between vitamin D supplementation and mammographic density change over time in women at high risk for breast cancer (2015) (0)
P2-159 Birthweight, postnatal growth, and age at menarche (2007) (0)
Abstract C095: Dense breast notification, breast density awareness, and breast cancer-related cognition and emotions in a predominantly Hispanic screening population (2020) (0)
Shared heritability and functional enrichment across six solid cancers (2019) (0)
Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers (2020) (0)
Male breast cancer in BRCA1 and BRCA2 mutation carriers (2018) (0)
Exposure to polycyclic aromatic hydrocarbons during pregnancy and breast tissue composition in adolescent daughters and their mothers: a prospective cohort study (2022) (0)
Performance of BCRAT in high-risk patients with breast cancer reply (2019) (0)
Cancer Education Interventions in Adolescents: A Systematic Review of Scope and Content (2022) (0)
Contribution of Occupational Risk Factors to Lifespan Inequalities across Socio-Occupational Groups in France (2022) (0)
Abstract B102: Multigenerational socioeconomic status and breast tissue composition in mothers and their adolescent daughters: Findings from a multiethnic cohort in New York City (2023) (0)
Epidemiology and Risk Factors for Breast Cancer: 21st Century Advances, Gaps to Address through Interdisciplinary Science. (2023) (0)
Abstract LB-290: The influence of body size and weight gain on global and gene promoter methylation in a population-based breast cancer study (2014) (0)
Abstract B24: Lifecourse socioeconomic factors and mammographic breast density (2011) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Mary Beth Terry?

Mary Beth Terry is affiliated with the following schools:

University of California, Berkeley
Rutgers University
University of Melbourne
Stanford University
University of Toronto
Columbia University
University of Cambridge

Mary Beth Terry's Academic­Influence.com Rankings

Mary Beth Terry's Degrees

Why Is Mary Beth Terry Influential?

Mary Beth Terry's Published Works

Published Works

What Schools Are Affiliated With Mary Beth Terry?

Mary Beth Terry's AcademicInfluence.com Rankings